Onward wins FDA approval for ARC-EX system in spinal cord injury patients
Shares in the company were up 7% at market open following the first approval for a non-invasive spinal cord stimulator for spinal cord injury (SCI) patients.
Medical Devices
Mainz Biomed partners with Quest for colorectal cancer screening test
Imbed Biosciences announces Terry Bromley as new CEO
Vivani begins exenatide implant trial for obesity in Australia
Karmanos Cancer Institute commences prescription of liver cancer device
Hologic agrees with CDC to develop reagents for H5N1 bird flu testing
ClearNote and Southampton researchers partner for pancreatic cancer test study
Dexcom implements GenAI into glucose biosensor devices
